0
0
NEW DELHI, March 16, 2026 — In a landmark development for the nation’s healthcare manufacturing landscape, India’s medical device exports have officially crossed the $4 billion threshold for the 2024–25 fiscal year. The surge comes as the government sets its sights on an ambitious $30 billion domestic market by 2030, signaling a strategic pivot from being the “Pharmacy of the World” to becoming a global hub for high-tech medical engineering.
The milestone was the focal point of a high-level “Chintan Shivir” (deliberative session) held this weekend at Vanijya Bhawan, organized by the Department of Commerce in collaboration with the Department of Pharmaceuticals and the Export Promotion Council for Medical Devices (EPCMD). The event brought together over 150 policymakers, industry leaders, and regulators to draft a roadmap for the “30@2030” vision—a plan to scale India’s global market share from its current 1.5% to double digits over the next decade.
A Structural Shift in Manufacturing
For decades, India has relied heavily on imports—meeting nearly 70–80% of domestic demand through foreign technology, particularly in high-end imaging and diagnostic equipment. However, recent data suggests the tide is turning.
Commerce Secretary Rajesh Agarwal emphasized that while the $4 billion export figure is a testament to current momentum, the next phase requires a leap into “high-value manufacturing.”
“India must move beyond its identity as the ‘Pharmacy of the World’ to emerge as a global MedTech manufacturing hub,” Agarwal stated. “This will require significant investments in research and development, incremental innovation, and, crucially, regulatory harmonization with global standards.”
The growth is currently led by the consumables and disposables segment, which accounts for nearly 47% of total exports. However, the government’s Production Linked Incentive (PLI) scheme is beginning to move the needle on complex electronics.
Key Drivers of Growth:
-
PLI Schemes: With an outlay of approximately ₹3,420 crore, the PLI scheme has already catalyzed the domestic production of 54 unique high-end devices, including MRI machines, CT scanners, and heart valves.
-
Infrastructure Clusters: Dedicated Medical Device Parks in states like Uttar Pradesh, Maharashtra, and Karnataka are providing manufacturers with shared testing labs and streamlined logistics.
-
Regulatory Reforms: The Central Drugs Standard Control Organisation (CDSCO) has implemented a risk-based classification system for over 500 devices, aligning Indian safety protocols with those used in the EU and U.S.
Bridging the Technology Gap
Despite the optimism, the sector faces a significant “trade deficit” challenge. While exports have hit $4 billion, imports for the same period stood at roughly $8.6 billion. The discrepancy is largely due to India’s continued reliance on “electro-medical” equipment—complex machines like ventilators and robotic surgical systems—which still make up 60% of all imports.
Aman Sharma, Joint Secretary at the Department of Pharmaceuticals, noted that quality assurance is the final frontier for global acceptance. “Both industry and regulators need to work together toward the objective of focusing on the quality of medical devices manufacturing. Precision and reliability are non-negotiable in healthcare,” Sharma said.
Industry Perspectives
Rajiv Nath, Forum Coordinator for the Association of Indian Medical Devices Industry (AiMeD), highlighted that while the manufacturing capacity exists—India can produce over 25,000 ventilators annually—policy “inertia” sometimes favors imported brands in government procurement.
“Continued government–industry collaboration is essential to address global regulatory barriers and scale domestic manufacturing capacity,” Nath remarked, calling for more “Made in India” preferences in hospital tenders to provide local firms the scale they need to compete globally.
What This Means for Public Health
For the average consumer, the growth of the domestic MedTech sector is more than just an economic statistic; it directly impacts the affordability and accessibility of healthcare.
-
Lower Costs for Patients: Domestically manufactured devices, such as stents or knee implants, can be 20% to 50% cheaper than their imported counterparts, potentially lowering the overall cost of surgeries.
-
Shorter Supply Chains: Local production ensures that critical equipment and spare parts are available even during global supply chain disruptions, similar to those seen during the COVID-19 pandemic.
-
Technological Tailoring: Indian firms are increasingly focusing on “frugal innovation”—designing portable, battery-operated diagnostic tools that can function in rural clinics with inconsistent power supplies.
Challenges and Counterarguments
While the $30 billion target is bold, some experts urge caution. Critics point out that “regulatory harmonization” is a double-edged sword. As India adopts stricter global standards (like the 2026 CDSCO update), many small and medium enterprises (MSMEs) may struggle with the high costs of compliance and clinical trials.
Furthermore, a recent report by Rubix Data Sciences suggests that while India is strong in cost-efficient manufacturing, it still lags in the “design engineering” and “IP creation” phases compared to global giants like Germany or the U.S. To reach the 2030 goal, the sector must transition from “making for the world” to “designing for the world.”
The Road to 2030
As the Chintan Shivir concluded, the consensus among stakeholders was clear: the foundation is laid. With the National Medical Devices Policy and the MedTech Mitra program providing a supportive framework, the next five years will be a test of India’s ability to innovate rather than just replicate.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
https://www.daijiworld.com/news/newsDisplay?newsID=1309176
